The market performance of Liminatus Pharma Inc has been somewhat unstable.
52-week price history of LIMN Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Liminatus Pharma Inc’s current trading price is -84.88% away from its 52-week high, while its distance from the 52-week low is 15.68%. The stock’s price range for this period has remained between $4.40 and $33.66. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.83 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.56 million over the last three months.
Financial Performance and Market Capitalization
Liminatus Pharma Inc (LIMN) has experienced a quarterly decline of -36.69% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 137.76M and boasts a workforce of 3 employees.
Moving average and trading volume data
LIMN Stock Stochastic Average
As of today, the raw stochastic average of Liminatus Pharma Inc over the last 50 days is at 3.02%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 17.18%. Further, the company’s Stochastic %K and %D values for the last 20 days were 20.40% and 23.73%, respectively.
LIMN Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Until today this year the stock’s price performance recorded a decrease of -50.77%. However, over the last six months, the performance has been stronger by -56.68%. The price of LIMN decreased -43.57% over the last 30 days. And in the last five days, it has fallen by -37.00%.
